Literature DB >> 17255772

Pulmonary light chain deposition disease: report of five cases and review of the literature.

Parul Bhargava1, Jeanne M Rushin, Eileen J Rusnock, Lawrence G Hefter, Teri J Franks, Sharda G Sabnis, William D Travis.   

Abstract

Light chain deposition disease (LCDD) in the lung is a rare occurrence. We describe 5 new cases of this entity, review the literature, and compare pulmonary light chain deposits to pulmonary amyloidosis. In addition, we identified 17 patients with pulmonary LCDD in the literature with sufficient clinical information to allow evaluation of clinical presentation, laboratory findings, histologic appearance, and disease progression. In these 22 patients, 2 different histologic patterns were appreciated: diffuse and nodular. A parallel with the diffuse and nodular forms of pulmonary amyloidosis is suggested. The 10 patients with nodular LCDD had an overall better prognosis compared with the 12 patients with diffuse pulmonary LCDD. However, when compared to what is reported in the literature for nodular pulmonary amyloidosis, the patients with nodular LCDD had a higher incidence of an associated lymphoproliferative and/or plasma cell dyscrasia and renal failure. Light chain deposits in the lung are histologically similar to amyloid but are not Congophilic. Their electron microscopic appearance is distinctly different with fibrils in amyloid and granular deposits in LCDD. As the diffuse forms of LCDD and amyloidosis have a similarly poor prognosis, differentiating the 2 entities is probably not critical. However, when present as nodules, LCDD is more frequently associated with an underlying plasma cell dyscrasia or renal failure than is amyloidosis, and therefore the distinction may be clinically important.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255772     DOI: 10.1097/01.pas.0000213358.18380.d2

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  Extraosseus plasmacytoma of the pharynx with localized light chain deposition. Case report.

Authors:  Nina Zidar; Samo Zver; Vesna Jurcić
Journal:  Pathol Oncol Res       Date:  2009-12-05       Impact factor: 3.201

Review 2.  Deposition-associated diseases related with a monoclonal compound.

Authors:  M J Molina-Garrido; C Guillén-Ponce; A Mora; M Guirado-Risueño; M A Molina; M J Molina; A Carrato
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

3.  Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor.

Authors:  Magali Colombat; Hervé Mal; Christiane Copie-Bergman; Jacques Diebold; Diane Damotte; Patrice Callard; Michel Fournier; Jean-Pierre Farcet; Marc Stern; Marie-Hélène Delfau-Larue
Journal:  Blood       Date:  2008-05-15       Impact factor: 22.113

Review 4.  Diffuse cystic lung diseases.

Authors:  Jay H Ryu; Xinlun Tian; Misbah Baqir; Kaifeng Xu
Journal:  Front Med       Date:  2013-05-11       Impact factor: 4.592

5.  Birt-Hogg-Dubé syndrome: metalloproteinase activity and response to doxycycline.

Authors:  Suzana Pinheiro Pimenta; Bruno Guedes Baldi; Ellen Caroline Toledo do Nascimento; Thais Mauad; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2012-12       Impact factor: 2.365

6.  Indolent systemic mastocytosis associated with light chain deposition disease.

Authors:  Kotaro Sasaki; Alice Chang; Behzad Najafian
Journal:  Clin Kidney J       Date:  2012-10

7.  [Clinical features and prognosis of patients with primary light chain deposition disease].

Authors:  J N Wang; J Feng; X X Cao; M H Duan; L Zhang; D B Zhou; J Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-03-14

8.  Nodular pulmonary deposition disease in a patient with the acquired immunodeficiency syndrome: a case report.

Authors:  Jessica N Mezzanotte; I-Sanna Gibbons-Fideler; Konstantin Shilo; Mark Lustberg; Srinivas Devarakonda
Journal:  J Med Case Rep       Date:  2020-06-04

9.  Pulmonary amyloidosis as the presenting finding in a patient with multiple myeloma.

Authors:  Ryan Kronen; David R Ziehr; Ashley E D Kane; Paul A VanderLaan; Cyrus A Kholdani; Robert W Hallowell
Journal:  Respir Med Case Rep       Date:  2022-03-18

10.  Free light chains: potential biomarker and predictor of mortality in alpha-1-antitrypsin deficiency and usual COPD.

Authors:  Judith A Hampson; Robert A Stockley; Alice M Turner
Journal:  Respir Res       Date:  2016-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.